Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Benowitz

Showing results (111-120 of 291) with videos related to

Pageof 30
Sort By:
Clinical Pharmacology and Therapeutics|October 1, 1986
Additive cardiovascular effects of nicotine and ethanolN L Benowitz, R T Jones, P Jacob
Clinical Pharmacology and Therapeutics|April 1, 1987
Influence of tobacco abstinence on the disposition kinetics and effects of nicotineB L Lee, N L Benowitz, P Jacob
Therapeutic Drug Monitoring|March 5, 1998
Evaluation of pharmacokinetic methods used to estimate caffeine clearance and comparison with a Bayesian forecasting methodC P Denaro, P Jacob, N L Benowitz
Pharmacogenetics|June 1, 1996
CYP2D6 phenotype and the metabolism of nicotine and cotinineN L Benowitz, P Jacob, E Perez-Stable
European Journal of Clinical Pharmacology|January 1, 1993
A clinical pharmacological study of subcutaneous nicotineJ Le Houezec, P Jacob, N L Benowitz
BMJ (Clinical Research Ed.)|April 22, 1989
Persistent increase in caffeine concentrations in people who stop smokingN L Benowitz, S M Hall, G Modin
Journal of Chromatography|September 29, 1989
Sulfonium salts as derivatizing agents. 2. Determination of theophylline in plasma by automated gas chromatographyB L Lee, P Jacob, N L Benowitz
Journal of Medicinal Chemistry|July 1, 1990
Synthesis of (3'R,5'S)-trans-3'-hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3'-hydroxycotinine in humans is highly stereoselectiveP Jacob, A T Shulgin, N L Benowitz
Pharmacology, Biochemistry, and Behavior|May 1, 1988
Recent studies of nicotine metabolism in humansP Jacob, N L Benowitz, A T Shulgin
Clinics in Dermatology|October 27, 1998
Clinical pharmacology of nicotineS Zevin, S G Gourlay, N L Benowitz
Pageof 30

Showing results (111-120 of 291) with videos related to

Sort By:
Pageof 30
Clinical Pharmacology and Therapeutics|October 1, 1986
Additive cardiovascular effects of nicotine and ethanolN L Benowitz, R T Jones, P Jacob
Clinical Pharmacology and Therapeutics|April 1, 1987
Influence of tobacco abstinence on the disposition kinetics and effects of nicotineB L Lee, N L Benowitz, P Jacob
Therapeutic Drug Monitoring|March 5, 1998
Evaluation of pharmacokinetic methods used to estimate caffeine clearance and comparison with a Bayesian forecasting methodC P Denaro, P Jacob, N L Benowitz
Pharmacogenetics|June 1, 1996
CYP2D6 phenotype and the metabolism of nicotine and cotinineN L Benowitz, P Jacob, E Perez-Stable
European Journal of Clinical Pharmacology|January 1, 1993
A clinical pharmacological study of subcutaneous nicotineJ Le Houezec, P Jacob, N L Benowitz
BMJ (Clinical Research Ed.)|April 22, 1989
Persistent increase in caffeine concentrations in people who stop smokingN L Benowitz, S M Hall, G Modin
Journal of Chromatography|September 29, 1989
Sulfonium salts as derivatizing agents. 2. Determination of theophylline in plasma by automated gas chromatographyB L Lee, P Jacob, N L Benowitz
Journal of Medicinal Chemistry|July 1, 1990
Synthesis of (3'R,5'S)-trans-3'-hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3'-hydroxycotinine in humans is highly stereoselectiveP Jacob, A T Shulgin, N L Benowitz
Pharmacology, Biochemistry, and Behavior|May 1, 1988
Recent studies of nicotine metabolism in humansP Jacob, N L Benowitz, A T Shulgin
Clinics in Dermatology|October 27, 1998
Clinical pharmacology of nicotineS Zevin, S G Gourlay, N L Benowitz
Pageof 30